Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 10/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8437232 | 0.94 | PRMT1 (0.59) | PRMT1TSHRADRA1AEPHX2 | |
| SCHEMBL19951569 | 0.90 | THRB (0.43) | PRMT1TSHRADRA1ATHRBEPHX2 | |
| SCHEMBL14582190 | 0.89 | TSHR (0.50) | PRMT1TSHRTHRBHTTPOLB | |
| SCHEMBL13589405 | 0.87 | TSHR (0.53) | PRMT1TSHRTHRBHTTPOLB | |
| SCHEMBL13589406 | 0.87 | TSHR (0.53) | PRMT1TSHRTHRBHTTPOLB | |
| SCHEMBL12511119 | 0.87 | TSHR (0.53) | PRMT1TSHRTHRBHTTPOLB | |
| SCHEMBL13589407 | 0.87 | TSHR (0.53) | PRMT1TSHRTHRBHTTPOLB | |
| SCHEMBL2195083 | 0.87 | THRB (0.52) | TSHRTHRBEPHX2HTTPOLB | |
| SCHEMBL19968189 | 0.86 | EPHX2 (0.44) | TSHRTHRBEPHX2 | |
| SCHEMBL29867913 | 0.85 | TSHR (0.41) | PRMT1TSHRTHRBEPHX2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024038338-A1 | FUNCTIONALIZED POROUS SUBSTRATES AND THEIR USE FOR DETECTING ANALYTES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-02-22 | — | — | WO | disclosed |
| CN-109689189-B | Functionalized copolymers and uses thereof | 3M创新有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20210031152-A1 | FUNCTIONALIZED COPOLYMERS AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2021-02-04 | — | — | US | disclosed |
| US-20210031152-A1 | FUNCTIONALIZED COPOLYMERS AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2021-02-04 | — | — | US | disclosed |
| EP-3509729-A1 | FUNCTIONALIZED COPOLYMERS AND USE THEREOF | 3M Innovative Properties Company (US) | 2019-07-17 | — | — | EP | disclosed |
| WO-2018048696-A1 | FUNCTIONALIZED COPOLYMERS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210031152-A1 | FUNCTIONALIZED COPOLYMERS AND USE THEREOF | CD44, ACP1, SPPL2B | PRMT1 1654/4885TSHR 2253/4885ADRA1A 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.